Related Experiment Videos
Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome
A Lacroix1, P Hamet, J M Boutin
1Department of Medicine, Research Center, Hôtel-Dieu du Centre Hospitalier de l'Université de Montréal, QC, Canada. andre.lacroix@umontreal.ca
The New England Journal of Medicine
|November 24, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
SDHC c.397C>T-related pheochromocytomas and paragangliomas: insights from an international study.
Endocrine-related cancer·2026
[Linking Interventional Cardiology clinical registry data with French hospital administrative data: Development and validation of deterministic record linkage].
Revue d'epidemiologie et de sante publique·2021
[Acute renal failure of the donor in encephalic death: A real contraindication to kidney transplantation?]
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2021
Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III study.
Journal of endocrinological investigation·2020
Pulmonary Nodules.
The New England journal of medicine·2026
Daraxonrasib for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer.
The New England journal of medicine·2026
Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.
The New England journal of medicine·2026
Catheter-Directed Thrombolysis in Intermediate-High-Risk Pulmonary Embolism.
The New England journal of medicine·2026
Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.
The New England journal of medicine·2026
Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.
The New England journal of medicine·2026
Self-defenestration associated with 3-MeO-PCE ingestion.
International journal of legal medicine·2026
Real-World Applicability of Anti-VEGF Trial Criteria for Diabetic Macular Edema.
American journal of ophthalmology·2026
YES1, a plasma-based biomarker for cavernous malformations.
Journal of neurosurgery. Pediatrics·2026